{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:00:30Z","timestamp":1792018830306,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.bbagen.2005.10.003","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T11:22:50Z","timestamp":1130498570000},"page":"200-206","source":"Crossref","is-referenced-by-count":25,"title":["Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine"],"prefix":"10.1016","volume":"1760","author":[{"given":"Mohammad A.","family":"Kamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz A.","family":"Al-Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Sheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2005.10.003_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(95)91556-7","article-title":"Is senile dementia \u2018age-related\u2019 or \u2018aging-related\u2019?\u2014Evidence from meta-analysis of dementia prevalence in the oldest old","volume":"346","author":"Ritchie","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2005.10.003_bib2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archpsyc.56.9.848","article-title":"Consensus statement on the upcoming crisis in geriatric mental health","volume":"56","author":"Jeste","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbagen.2005.10.003_bib3","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2174\/1381612043383331","article-title":"Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents","volume":"10","author":"Lahiri","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbagen.2005.10.003_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/NMM:1:1:1","article-title":"Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease","volume":"1","author":"Sambamurti","year":"2002","journal-title":"Neur. Mol. Med."},{"key":"10.1016\/j.bbagen.2005.10.003_bib5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2005.10.003_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(79)90336-6","article-title":"Neurotransmitter-related enzymes in senile dementia of the Alzheimer type","volume":"171","author":"Davies","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.bbagen.2005.10.003_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0959-4388(95)80022-0","article-title":"Ageing: the cholinergic hypothesis of cognitive decline","volume":"5","author":"Gallagher","year":"1995","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbagen.2005.10.003_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/bmj.323.7305.123","article-title":"Drugs for Alzheimer's disease","volume":"323","author":"O'Brien","year":"2001","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbagen.2005.10.003_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/ajp.157.1.4","article-title":"Cholinesterase inhibitors: a new class of psychotropic compounds","volume":"157","author":"Cummings","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbagen.2005.10.003_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1176\/appi.ajp.157.5.708","article-title":"Mental and behavioural disturbances in dementia: findings from the Cache County Study on Memory in Aging","volume":"157","author":"Lykestos","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbagen.2005.10.003_bib11","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","article-title":"Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia","volume":"2","author":"Perry","year":"1978","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbagen.2005.10.003_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0197-0186(92)90189-X","article-title":"Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development\u2014A study of molecular forms","volume":"21","author":"Arendt","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbagen.2005.10.003_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF00296744","article-title":"Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains","volume":"87","author":"Moran","year":"1994","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.bbagen.2005.10.003_bib14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.410420613","article-title":"Butyrylcholinesterase in the life cycle of amyloid plaques","volume":"42","author":"Guillozet","year":"1997","journal-title":"Ann. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbagen.2005.10.003_bib15","first-page":"1","article-title":"Butyrylcholinesterase in health and disease","volume":"25","author":"Mesulam","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2005.10.003_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer's disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.bbagen.2005.10.003_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.bbagen.2005.10.003_bib18","series-title":"Butyrylcholinesterase: Its Function and Inhibition","first-page":"69","article-title":"Butyrylcholinesterase: its selective inhibition and relevance to Alzheimer's disease","author":"Greig","year":"2003"},{"issue":"9427","key":"10.1016\/j.bbagen.2005.10.003_bib19","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(04)16499-4","article-title":"Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial","volume":"363","author":"Courtney","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2005.10.003_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1532-5415.2005.53015.x","article-title":"Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition","volume":"53","author":"Lopez","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bbagen.2005.10.003_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterases in senile dementia of Alzheimer type","volume":"4","author":"Perry","year":"1978","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"4","key":"10.1016\/j.bbagen.2005.10.003_bib22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbagen.2005.10.003_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00008571-200304000-00008","article-title":"Regulation of attention and response to therapy in dementia by butyrylcholinesterase","volume":"13","author":"O'Brien","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bbagen.2005.10.003_bib24","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/01.WNL.0000068336.84399.9E","article-title":"Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies","volume":"60","author":"Perry","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2005.10.003_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1586\/14737175.5.1.101","article-title":"Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment","volume":"5","author":"Tasker","year":"2005","journal-title":"Expert Rev. Neurotherapeutics"},{"key":"10.1016\/j.bbagen.2005.10.003_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000084705","article-title":"The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients","volume":"19","author":"Ballard","year":"2005","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.bbagen.2005.10.003_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1567205054367838","article-title":"Cholinesterases: roles in the brain during health and disease","volume":"2","author":"Ballard","year":"2005","journal-title":"Cur. Alz. Res."},{"key":"10.1016\/j.bbagen.2005.10.003_bib28","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1021\/jm980459s","article-title":"Phenserine-based synthesis of novel selective inhibitors of butyrylcholinesterase for Alzheimer's disease","volume":"42","author":"Yu","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2005.10.003_bib29","first-page":"3","article-title":"Phenserine and ring-C hetero-analogues: drug candidates for the treatment of Alzheimer's disease","volume":"15","author":"Greig","year":"1995","journal-title":"Med. Chem. Rev."},{"key":"10.1016\/j.bbagen.2005.10.003_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1567205054367829","article-title":"An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease","volume":"2","author":"Greig","year":"2005","journal-title":"Cur. Alz. Res."},{"key":"10.1016\/j.bbagen.2005.10.003_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/bbrc.1998.8931","article-title":"Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine","volume":"248","author":"Al-Jafari","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2005.10.003_bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0006-2952(00)00330-0","article-title":"Kinetics of human acetylcholinesterase inhibition by novel experimental Alzheimer therapeutic agent, tolserine","volume":"60","author":"Kamal","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2005.10.003_bib33","first-page":"323","article-title":"Kinetics of rat brain acetylcholinesterase inhibition by two experimental Alzheimer's disease drugs, phenserine and tolserine","volume":"4","author":"Al-Jafari","year":"2000","journal-title":"J. Biochem. Mol. Biol. Biophys."},{"issue":"3","key":"10.1016\/j.bbagen.2005.10.003_bib34","first-page":"333","article-title":"A new, simple and economical approach to analyse the inhibition kinetics of acetylcholinesterase using tolserine","volume":"20","author":"Kamal","year":"2002","journal-title":"Emir. Med. J."},{"key":"10.1016\/j.bbagen.2005.10.003_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.bbagen.2005.10.003_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1023\/A:1022869222652","article-title":"Cholinesterases: new roles in brain function and in Alzheimer's disease","volume":"28","author":"Giacobini","year":"2003","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.bbagen.2005.10.003_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1074-7427(03)00076-5","article-title":"Cholinergic modulation of learning and memory in the human brain as detected with functional neuroimaging","volume":"80","author":"Thiel","year":"2003","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.bbagen.2005.10.003_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00424-002-0999-2","article-title":"Cholinergic modulation of the cortical neuronal network","volume":"44","author":"Lucas-Meunier","year":"2003","journal-title":"Pflugers Arch."},{"issue":"24","key":"10.1016\/j.bbagen.2005.10.003_bib39","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1021\/jm010080x","article-title":"Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure\/activity relationships for acetyl- and butyrylcholinesterase inhibitory action","volume":"44","author":"Yu","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2005.10.003_bib40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/35067589","article-title":"Acetylcholinesterase\u2014New roles for an old actor","volume":"2","author":"Soreq","year":"2001","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.bbagen.2005.10.003_bib41","series-title":"Cholinesterases and Cholinesterase Inhibitors","first-page":"81","article-title":"Molecular forms and anchoring of acetylcholinesterase","author":"Massoulie","year":"2000"},{"key":"10.1016\/j.bbagen.2005.10.003_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0968-0004(92)90314-Y","article-title":"Excavations into the active-site gorge of cholinesterases","volume":"17","author":"Soreq","year":"1992","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbagen.2005.10.003_bib43","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1021\/bi011652i","article-title":"3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates","volume":"41","author":"Dvir","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2005.10.003_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0009-2797(99)00012-5","article-title":"A preliminary comparison of structural models for catalytic intermediates of acetylcholinesterase","volume":"119\u2013120","author":"Silman","year":"1999","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbagen.2005.10.003_bib45","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1042\/bst0220745","article-title":"Three-dimensional structures of acetylcholinesterase and of its complexes with anticholinesterase agents","volume":"22","author":"Silman","year":"1994","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbagen.2005.10.003_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/0-387-23226-5_15","article-title":"Acetylcholinesterase interaction with Alzheimer amyloid beta","volume":"38","author":"Inestrosa","year":"2005","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbagen.2005.10.003_bib47","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0006-3495(96)79759-X","article-title":"Electrooptical measurements demonstrate a large permanent dipole moment associated with acetylcholinesterase","volume":"4","author":"Porschke","year":"1996","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbagen.2005.10.003_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1093-3263(98)00005-9","article-title":"External and internal electrostatic potentials of cholinesterase models","volume":"15","author":"Felder","year":"1997","journal-title":"J. Mol. Graphics Modell."},{"key":"10.1016\/j.bbagen.2005.10.003_bib49","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/jm049309+","article-title":"Novel anticholinesterases based on the molecular skeletons of furobenzofuran and benzodioxepine","volume":"48","author":"Luo","year":"2005","journal-title":"J. Med. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441650500320X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441650500320X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T13:28:23Z","timestamp":1548077303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030441650500320X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S030441650500320X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2005.10.003","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}